| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11:30 | Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; Eli Lilly Acquires CNTA; BIIB Snaps Up APLS | 1.155 | AFX News | BASEL (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., EU, and China, acquisitions, a few key trial goal misses and positive clinical trial data readouts... ► Artikel lesen | |
| 11:10 | Evotec-Aktie: Neuzugang könnte neue Hoffnungen wecken | 708 | sharedeals.de | Die Evotec-Aktie blieb in der schwachen Phase der Börsen stabil und konnte sich entgegen dem Trend leicht erholen. Am Donnerstag ging sie mit einem Gewinn von +2,2% aus dem Handel und steht bei rund... ► Artikel lesen | |
| 15:15 | BASF: Party vorbei? - Deutsche Rohstoff, Deutsche Telekom, Evotec, Mutares und Viscom - Börse Frankfurt | 642 | 4investors | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| 11:10 | Evotec-Aktie vor Zahlen: Darum ist der 8. April entscheidend | 612 | sharedeals.de | Am 8. April richtet sich der Blick vieler Anleger auf den Wirkstoffforscher Evotec. Das Hamburger Unternehmen wird an diesem Tag seine Ergebnisse für das vierte Quartal und das Gesamtjahr 2025 veröffentlichen... ► Artikel lesen | |
| 09:10 | NEC Corporation: Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer | 563 | JCN Newswire | Strasbourg, France & Schiphol, Netherlands, Apr 3, 2026 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment... ► Artikel lesen | |
| Do | Sharp Therapeutics Corp.: Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering | 510 | Newsfile | Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 2, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has... ► Artikel lesen | |
| Do | OS Therapies: OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors | 503 | Newsfile | Company expects approximately $2 million in non-dilutive VAT refunds from wholly owned U.K. subsidiary in 2Q-26Company expects to receive approximately $2 million in non-dilutive R&D tax credits... ► Artikel lesen | |
| 08:00 | NurExone baut US-Standbein aus - Exo-Top rückt in den strategischen Fokus | Small- & Micro Cap Investment | |||
| 15:14 | Evotec vor Kurssprung? Analysten und Charttechnik signalisieren Aufwärtspotenzial! | RuMaS | |||
| Do | TriNetX, LLC.: TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions | 321 | PR Newswire | Under the collaboration, TriNetX will provide Regeneron with secure, licensed access to TriNetX's current and future de-identified health data from approximately 300 million individuals (170 million... ► Artikel lesen | |
| 07:06 | Innate Pharma SA: Innate Pharma to Participate in the Kempen Life Sciences Conference | 309 | Business Wire | Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced... ► Artikel lesen | |
| 17:06 | GenSight Biologics Confirms Definitive Full-Year 2025 Consolidated Financial Results Are in Line with Estimates | 281 | Business Wire | Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal... ► Artikel lesen | |
| Do | Minerva Neurosciences, Inc: Minerva Announces Leadership Transition | 264 | GlobeNewswire (Europe) | Jim O'Connor joins as Chief Business Officer and General CounselBURLINGTON, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company... ► Artikel lesen | |
| Do | DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 | 259 | GlobeNewswire (Europe) | Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market... ► Artikel lesen | |
| Do | KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 236 | Business Wire | KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Compensation Committee of KalVista's Board of Directors granted five newly-hired employees inducement options to purchase an... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| SIGA TECHNOLOGIES | 5,250 | 0,52 | +9,90 % | 0,60 | 07.04.2026 | |
| BB BIOTECH | 47,850 | 2,47 | +5,16 % | 2,25 | 23.03.2026 | |
| CSL | 83,33 | 2,61 | +3,13 % | 1,84 | 10.03.2026 | |
| AMGEN | 301,50 | 8,32 | +2,76 % | 2,52 | 15.05.2026 | |
| RECORDATI | 48,620 | 1,30 | +2,67 % | 0,71 | 18.05.2026 | |
| NOVONESIS | 51,64 | 0,87 | +1,68 % | 4,25 | 20.03.2026 | |
| SINO BIOPHARM | 0,698 | 0,01 | +1,43 % | 0,05 | 24.06.2026 | |
| GENUS | 27,600 | 0,38 | +1,38 % | 0,11 | 05.03.2026 | |
| BIOMERIEUX | 92,60 | 0,90 | +0,97 % | 0,98 | 09.06.2026 | |
| BIO-TECHNE | 45,800 | 0,27 | +0,59 % | 0,08 | 13.02.2026 |